Using geospatial modeling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa

Antiretroviral-based pre-exposure HIV interventions may soon be rolled out in resource-constrained Sub-Saharan African countries, but rollout plans have yet to be designed. Here we use geospatial modeling and optimization techniques to compare two rollout plans for ARV-based microbicides in South Africa: a utilitarian plan that minimizes incidence by using geographic targeting, and an egalitarian plan that maximizes geographic equity in access to interventions. We find significant geographic variation in the efficiency of interventions in reducing HIV transmission, and that efficiency increases disproportionately with increasing incidence. The utilitarian plan would result in considerable geographic inequity in access to interventions, but (by exploiting geographic variation in incidence) could prevent ~40% more infections than the egalitarian plan. Our results show that the geographic resource allocation decisions made at the beginning of a rollout, and the location where the rollout is initiated, will be crucial in determining the success of interventions in reducing HIV epidemics.

[1]  J. Yorke,et al.  Gonorrhea Transmission Dynamics and Control , 1984 .

[2]  L. V. Van Bortel,et al.  Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. , 2009, AIDS research and human retroviruses.

[3]  A. Wald,et al.  Genital herpes and human immunodeficiency virus: double trouble. , 2004, Bulletin of the World Health Organization.

[4]  J. Changalucha,et al.  The epidemiology of HIV among young people in sub-Saharan Africa: know your local epidemic and its implications for prevention. , 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[5]  A. Nizam,et al.  Containing Bioterrorist Smallpox , 2002, Science.

[6]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[7]  D. Ho,et al.  Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus , 2014, Science.

[8]  Lynn Morris,et al.  Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women , 2010, Science.

[9]  R. Mackie,et al.  Double trouble. , 1989, Nursing times.

[10]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[11]  L. Corey Synergistic copathogens--HIV-1 and HSV-2. , 2007, The New England journal of medicine.

[12]  S. Blower,et al.  Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: The effect of the urban–rural divide , 2006, Proceedings of the National Academy of Sciences.

[13]  Hadi Dowlatabadi,et al.  Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .

[14]  H. Weiss,et al.  The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis , 2011, AIDS.

[15]  Sally Blower,et al.  HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis , 2010, Proceedings of the National Academy of Sciences.

[16]  Arielle Lasry,et al.  A model for allocating CDC’s HIV prevention resources in the United States , 2011, Health care management science.

[17]  S. A. Abdool Karim,et al.  Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial , 2011, Trials.

[18]  S. Blower,et al.  A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control , 2012, AIDS.

[19]  R. Walensky,et al.  HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  S. Blower,et al.  Current drivers and geographic patterns of HIV in Lesotho: implications for treatment and prevention in Sub-Saharan Africa , 2013, BMC Medicine.

[21]  Dirk P. Kroese,et al.  Controlling the number of HIV infectives in a mobile population. , 2008, Mathematical biosciences.

[22]  A. Wald,et al.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. , 2002, The Journal of infectious diseases.

[23]  T. Fako,et al.  The geography of HIV/AIDS prevalence rates in Botswana , 2012, HIV/AIDS.

[24]  Mapping HIV epidemics in sub-Saharan Africa with use of GPS data. , 2013, The Lancet. Global health.

[25]  R. Walensky,et al.  The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South Africa , 2011, Journal of acquired immune deficiency syndromes.

[26]  A. Mindel,et al.  Epidemiology of herpes and HIV co-infection. , 2004, Journal of HIV therapy.

[27]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[28]  Ashley A. Eggman,et al.  Cost–effectiveness of pre-exposure prophylaxis for HIV: a review , 2012, Current opinion in HIV and AIDS.

[29]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[30]  Erin N. Bodine,et al.  Evolutionary Dynamics of Complex Networks of HIV Drug-Resistant Strains: The Case of San Francisco , 2010, Science.

[31]  B. Herold,et al.  Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges , 2013, Proceedings of the National Academy of Sciences.

[32]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[33]  Richard J Hayes,et al.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.

[34]  J.-J. Simond,et al.  Double trouble , 1999, IEEE Industry Applications Magazine.

[35]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[36]  S. Self,et al.  Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa , 2008, PloS one.

[37]  F. Schmidt Meta-Analysis , 2008 .

[38]  R. Walensky,et al.  Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. , 2012, The Journal of infectious diseases.

[39]  L. Alkema,et al.  A Bayesian approach to uncertainty analysis of sexually transmitted infection models , 2009, Sexually Transmitted Infections.

[40]  R. Walensky,et al.  The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.